Trade Gilead GILD

Sell
 Buy

Gilead live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

Gilead News

Ghko B 2026 Mar 01, 16:01

Vanguard S&P 500 ETF forecast 2026: Will VOO stock continue to go up?

Ghko B 2026 Mar 01, 16:00

Oil price forecast 2026: Oil prices surge, will the Iran conflict drive oil prices higher?

Ghko B 2026 Feb 27, 16:00

Crypto market outlook 2026: How the Middle East is Shaping Bitcoin's Future?

Frances Wang 2026 Feb 27, 16:00

European stocks analysis: What's going on in Europe stock market?

Ghko B 2026 Feb 27, 16:00

Market Sentiment Analysis: The Impact of S&P 500 on UAE Investor Confidence

Ghko B 2026 Feb 27, 16:00

Gold (XAUUSD) price forecast: Will XAU/USD reach $6,000 per ounce?

Ghko B 2026 Feb 26, 16:00

Best dividend stocks to watch: Medtronic MDT, Blackstone BX, Duke Energy DUK

Ghko B 2026 Feb 26, 16:00

Trending stocks in UAE stock market: Talabat Holding, ADNOC, Dana Gas

Ghko B 2026 Feb 25, 16:00

United Arab Emirates stock market analysis: What are the key market drivers?

Noah Lee 2025 Nov 10, 09:10

x402 Ecosystem Competition Analysis: Launchpads, Facilitators, and Providers

Latest news

Show more
Noah Lee 2025 Dec 06, 17:50

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

Noah Lee 2025 Dec 06, 17:00

Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Liam James 2025 Dec 06, 12:40

Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Ava Grace 2025 Dec 06, 11:50

Market Movers: Fed Rate Decision & Key Economic Data in Focus Next Week

Noah Lee 2025 Dec 06, 10:50

Central Bank Rate Decisions & Market Volatility Outlook: What to Expect

Emma Rose 2025 Dec 06, 09:40

Clear Street Prepares for IPO Amid Crypto Treasury Model Concerns

Ava Grace 2025 Dec 06, 09:30

Crypto Market Analysis and Regulatory Updates: December 6, 2024

Sophia Claire 2025 Dec 06, 08:00

Bitcoin Treasury Firms Face 'Darwinian Phase' Amid Market Shift

Info

Spread

0.92

Spread (%)

0.6194 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Monday

14:31 - 20:59

Tuesday

14:31-20:59

Wednesday

14:31-20:59

Thursday

14:31-20:59

Friday

14:31-20:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

184909578240

Shares Outstanding

1241420528

Earnings Date (Next)

2013-01-28

Div Yield

2026-03-30

Ex-Dividend Date

2026-03-13

Forward annual dividend rate

3.28

Forward annual dividend yield

0.022

EPS

6.78

Learn more about this instrument

Gilead Gilead Sciences Inc
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Descovy, Genvoya, Odefsey, Sunlenca, Symtuza, and YeztugoFor the treatment of HIV-1 infection in patients. It also provides Epclusa, Livdelzi, and Vemlidy to treat chronic hepatitis C virus, primary biliary cholangitis, and chronic hepatitis B virus; Tecartus, a T-cell therapy for the treatment of adult patients; Trodelvy, an injection for intravenous use; and Yescarta, a suspension for intravenous infusion, is a CAR T-cell therapy for the treatment of adult patients. Further, it provides AmBisome, for the treatment of serious invasive fungal infections; and Veklury for the treatment of COVID-19. The company has collaboration agreements with Shenzhen Pregene Biopharma Co., Ltd.; Abingworth; Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company has a collaboration with Terray Therapeutics, Inc. to discover and develop small molecule therapies; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company was incorporated in 1987 and is headquartered in Foster City, California.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments

Latest Education Articles

Show more
Ghko B 2026 Mar 01, 16:00

CFD Trading & Markets: How do I register for CFD trading in the United Arab Emirates (UAE)?

Ghko B 2026 Feb 26, 16:00

CFD Trading & Markets: How to start CFD trading in United Arab Emirates?

Ghko B 2026 Feb 24, 16:00

Forex trading and currency market: how to learn to trade forex?

Trustpilot